Tag: Kenya

Ten years of surveillance finds a variable but persistently high typhoid burden in Kibera, Kenya

Posted on June 14, 2023 by Eric Ng’eno, Kenya Medical Research Institute (KEMRI)

Typhoid remains a public health threat in many countries, particularly in Southeast Asia and sub-Saharan Africa. Understanding a country’s typhoid burden is often one of the first steps toward prevention ...

a healthy vaccine market can increase uptake

Building a stronger market: The benefits of investing in more TCVs

Posted on May 2, 2023 by Patricia Njuguna, PATH

Typhoid is a persistent threat to the health and well-being of millions of people living in low- and middle-income countries where the disease is endemic; there are approximately 9 million ...

In Kenya, advancing typhoid vaccine science and policy

Posted on October 10, 2022 by Dr. Frederick Sawe and Dr. Lucy Koech, KEMRI/HJFMRI, Kericho

Last month in Kericho, Kenya, our team was proud to launch a Phase 3 study of the EuTCV typhoid conjugate vaccine (TCV) candidate. As principal investigators based at Kenya Medical ...

Team of KEMRI field scientists in Mukuru, Kenya

In Kenya, typhoid carriage in children highlights need for vaccination

Posted on September 13, 2021 by Prof. Sam Kariuki and Dr. Zoe Dyson

Drug-resistant typhoid is endemic to Kenya, with children younger than 16 years of age most heavily impacted. We have known this for years. What we didn’t know was the prevalence ...

Angela Godfrey, age 26, and her daughter Sara Kambua, age 5, wait in the health clinic in Mukuru, Kenya, February 5, 2018.

Stories of Typhoid: Sara’s Typhoid Test

Posted on February 25, 2021 by Oumou Dao, Sabin Vaccine Institute

Angela Godfrey and her daughter Sara Kambua wait in the health clinic in Mukuru, Kenya. February 5, 2018. It was a Monday in February 2018 when three-year-old Sara had ...

Multidrug-resistant iNTS: A growing threat in Kenya

Posted on September 22, 2020 by Sam Kariuki, Director, Research and Development, Kenya Medical Research Institute

This blog is part of a broader series on drug resistance and its increasing threat to global health. Drug resistance is a significant and growing problem across the world for ...

Stories of Typhoid: In the Lab with Timothy Mutuma

Posted on August 17, 2020 by Noah Duff, Sabin Vaccine Institute

Timothy Mutuma has been working as a research assistant for the past two years, balancing his time between the clinics in the informal settlements of Mbagathi and Mukuru and the ...

Stories of Typhoid: A Mukuru family

Posted on July 2, 2020 by Noah Duff, Sabin Vaccine Institute

“We didn’t know about typhoid,” Mercy said in her one-room home in Mukuru, an informal settlement east of Nairobi, Kenya. That changed quickly for Mercy, her husband Mbuvi, and their ...

Stories of Typhoid: Gift King’Oo

Posted on February 3, 2020 by Noah Duff, Sabin Vaccine Institute

Meet Gift King’Oo, a one-year-old boy visiting the community health clinic in Mukuru, Kenya, an informal settlement just outside of Nairobi. In February 2018, Gift started getting sick, exhibiting common ...

Children in the African region, such as these children in Kenya, have a lot to gain from typhoid conjugate vaccine introduction.

Our time is now: typhoid as a priority for the African region

Posted on November 12, 2019 by Chris Odero, Technical Advisor, PATH

This week I am in Brazzaville, Congo to attend the Regional Immunization Technical Advisory Group (RITAG) meeting organized by the World Health Organization (WHO) African region office. The RITAG meeting ...

1 2 »